空间时空电图分散切除与肺静脉隔离在持续性心房的有效性和安全性:一个元分析
Patavee Pajareya1, Ponthakorn Kaewkanha1, Boone Singtong2
1Division of Cardiovascular Medicine, Center of Excellence in Arrhythmia Research, Cardiac Center, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
Journal of cardiovascular electrophysiology
|August 4, 2025
概括
与肺静脉隔离 (PVI) 结合的空间时空电图分散 (STED) 切除可显著减少心房的复发,并改善持续心房 (PsAF) 患者的鼻节律转换. 这种结合方法在治疗PsAF方面是安全有效的.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗技术 医疗技术 医学技术
背景情况:
- 肺静脉隔离 (PVI) 是持续性心房动 (PsAF) 的首要治疗方法.
- 由于复杂的PsAF机制,PVI单独具有适度的疗效.
- 时空电图分散 (STED) 切除提供了一种改善结果的潜在策略.
研究的目的:
- 在PsAF患者中,评估STED切除加PVI的疗效和安全性,与PVI单独相比.
- 评估STED切除对AF复发和鼻腔节律转换的影响.
主要方法:
- 系统搜索研究直到2024年11月.
- 包括的研究比较了PVI加STED切除 (PVI-STED组) 与PVI单独 (PVI组).
- 主要结局是AF复发和鼻节律 (SR) 转换.
主要成果:
- 分析了11项涉及1607名患者的研究.
- 在PVI-STED组显示显著较低的AF复发率 (OR:0.40) 和更高的SR转换率 (OR:7.04).
- 在手术,切除或光镜时间上没有显著差异;在PVI-STED组中不良事件率低 (1%).
结论:
- 在治疗PsAF时,PVI-STED方法是有效的.
- 综合策略证明了改善的疗效,减少了AF复发和增强了SR转化.
- PVI-STED方法是对PsAF的安全和有前途的治疗选择.
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
165
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
165
Dysrhythmias VI: Management of Dysrhythmias
107
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
107


